Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Guogang Tu"'
Publikováno v:
Journal of Molecular Modeling. 28
Epidermal growth factor receptor (EGFR) is highlighted as a target for anticancer treatment. Several EGFR inhibitors were approved in cancer treatment. Comparatively, 5D-QSAR is a new methodology which considers an ensemble of different induced-fit m
Publikováno v:
Molecular Diversity. 26:757-768
Histone deacetylases (HDACs) were highlighted as a novel category of anticancer targets. Several HDACs inhibitors were approved for therapeutic use in cancer treatment. Comparatively, receptor-dependent 4D-QSAR, LQTA-QSAR, is a new approach which gen
Epidermal growth factor receptor is a preferred target for treating cancer. Compared to 3D-QSAR, 4D-QSAR has the feature of conformational flexibility and free alignment for individual ligands. In present studies, the 4D-QSAR of 131 analogs of 4-anil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::666b95ef46e93f08fb39c041b3e8328a
https://doi.org/10.21203/rs.3.rs-1120590/v1
https://doi.org/10.21203/rs.3.rs-1120590/v1
Publikováno v:
Die Pharmazie. 73(3)
The aminopeptidase N (APN) plays a critical role in angiogenesis and is over-expressed in tumor cells. In this paper, we report the synthesis and enzyme inhibition assay of furoic peptidomimetic compounds. These new compounds exhibit potent inhibitor
Autor:
Guogang Tu1 tugg199@yahoo.com, Yugang Yan1, Xueying Chen2, Qiaoli Lv1, Jiaqi Wang1, Shaohua Li1
Publikováno v:
Drug Discoveries & Therapeutics. Apr2013, Vol. 7 Issue 2, p58-65. 8p.
Publikováno v:
Farmacia; 2020, Vol. 68 Issue 2, p362-368, 7p
Autor:
Yijing Liao, Xiaoqing Liu, Chao Liu, Gang Zhou, Wei Wang, Xi Mai, Haijun Zhong, Guogang Tu, Huiming Huang, Bin Wang
Publikováno v:
Asian Journal of Chemistry. 25:8587-8592